Fludarabine Phosphate



Indications and Reactions:

Role Indications Reactions
Primary
Chronic Lymphocytic Leukaemia 26.2%
Bone Marrow Conditioning Regimen 9.6%
Prophylaxis Against Graft Versus Host Disease 9.3%
Stem Cell Transplant 9.2%
Acute Myeloid Leukaemia 6.3%
Prophylaxis 5.5%
Non-hodgkin's Lymphoma 4.4%
B-cell Lymphoma 4.3%
Antifungal Prophylaxis 3.4%
Mantle Cell Lymphoma 3.3%
Infection Prophylaxis 3.0%
Antiviral Prophylaxis 2.6%
Drug Use For Unknown Indication 2.3%
Cord Blood Transplant Therapy 1.9%
Metastatic Malignant Melanoma 1.8%
Immunosuppression 1.5%
Bone Marrow Transplant 1.4%
B-cell Small Lymphocytic Lymphoma 1.4%
Chemotherapy 1.4%
Malignant Melanoma 1.2%
Thrombocytopenia 9.8%
Vomiting 8.2%
Pyrexia 7.7%
Neutropenia 6.0%
Sepsis 6.0%
Blood Stem Cell Harvest Failure 5.7%
Premature Menopause 5.7%
Myelodysplastic Syndrome 5.5%
Renal Failure 4.9%
Progressive Multifocal Leukoencephalopathy 4.6%
Respiratory Failure 4.6%
Acute Myeloid Leukaemia 4.1%
Pancytopenia 4.1%
Septic Shock 3.8%
White Blood Cell Count Decreased 3.8%
Myeloid Leukaemia 3.3%
Renal Failure Acute 3.3%
Transplant Failure 3.3%
Off Label Use 2.7%
Pulmonary Oedema 2.7%
Secondary
Chronic Lymphocytic Leukaemia 31.3%
Drug Use For Unknown Indication 12.0%
Product Used For Unknown Indication 7.0%
Prophylaxis 5.4%
Stem Cell Transplant 4.9%
B-cell Lymphoma 4.7%
Acute Myeloid Leukaemia 4.5%
Non-hodgkin's Lymphoma 4.5%
Mantle Cell Lymphoma 3.6%
Bone Marrow Conditioning Regimen 3.4%
Prophylaxis Against Graft Versus Host Disease 3.2%
Lymphoma 3.1%
Premedication 2.7%
Multiple Myeloma 1.9%
Infection Prophylaxis 1.7%
Graft Versus Host Disease 1.4%
Bone Marrow Transplant 1.2%
Acute Lymphocytic Leukaemia 1.2%
Immunosuppression 1.1%
Ewing's Sarcoma 1.1%
Febrile Neutropenia 13.1%
Myelodysplastic Syndrome 8.3%
Progressive Multifocal Leukoencephalopathy 6.7%
Sepsis 6.6%
Neutropenia 6.4%
Pneumonia 6.2%
Vomiting 6.0%
Pyrexia 5.7%
Thrombocytopenia 4.9%
White Blood Cell Count Decreased 4.1%
Blood Stem Cell Harvest Failure 3.9%
Death 3.9%
Acute Myeloid Leukaemia 3.6%
Septic Shock 3.6%
Graft Versus Host Disease 3.2%
Pancytopenia 3.2%
Respiratory Failure 3.1%
Thrombotic Microangiopathy 2.7%
Cytomegalovirus Infection 2.4%
Premature Menopause 2.4%
Concomitant
Product Used For Unknown Indication 14.1%
Bone Marrow Conditioning Regimen 13.3%
Prophylaxis Against Graft Versus Host Disease 13.3%
Stem Cell Transplant 9.2%
Infection Prophylaxis 9.1%
Prophylaxis 9.0%
Chronic Lymphocytic Leukaemia 3.9%
Premedication 3.8%
Drug Use For Unknown Indication 3.5%
Antifungal Prophylaxis 2.9%
Cord Blood Transplant Therapy 2.7%
Acute Myeloid Leukaemia 2.4%
Antibiotic Prophylaxis 1.9%
Antiviral Prophylaxis 1.9%
Non-hodgkin's Lymphoma 1.9%
B-cell Lymphoma 1.8%
Graft Versus Host Disease 1.5%
Aplastic Anaemia 1.3%
Bone Marrow Transplant 1.3%
Prophylaxis Of Nausea And Vomiting 1.2%
Acute Graft Versus Host Disease 9.5%
Progressive Multifocal Leukoencephalopathy 8.9%
Stomatitis 7.9%
Thrombotic Microangiopathy 7.7%
Vomiting 7.4%
Pyrexia 7.2%
Venoocclusive Liver Disease 6.3%
Stem Cell Transplant 5.0%
Drug Ineffective 4.7%
Sepsis 4.7%
White Blood Cell Count Decreased 4.3%
Death 3.4%
Graft Versus Host Disease 3.2%
Acute Graft Versus Host Disease In Skin 3.1%
Febrile Neutropenia 3.1%
Thrombocytopenia 3.1%
Septic Shock 2.8%
Neutropenia 2.7%
Acute Myeloid Leukaemia 2.6%
Pneumonia 2.6%
Interacting
Lymphoma 50.0%
Chronic Lymphocytic Leukaemia 12.0%
Epilepsy 10.0%
Non-hodgkin's Lymphoma 10.0%
Nausea 8.0%
Prophylaxis 4.0%
Anticoagulant Therapy 2.0%
Deep Vein Thrombosis 2.0%
Pneumonitis 2.0%
Nausea 62.5%
Anticoagulation Drug Level Above Therapeutic 12.5%
Leukopenia 12.5%
Sepsis 12.5%